Crossmark

Therapeutic innovations for the symptomatic treatment of Parkinson’s disease: focus on technology-based therapies

Crossref DOI link: https://doi.org/10.1007/s00702-025-02915-1

Published Online: 2025-03-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Jeryl Ritzi T. https://orcid.org/0000-0002-8052-4140
Kundrick, Avery https://orcid.org/0000-0003-4578-3777
Panganiban, Enrique C. https://orcid.org/0009-0006-5330-1263
Sy, Michelle Ann https://orcid.org/0000-0001-7130-7569
Anis, Saar https://orcid.org/0000-0002-6448-4505
Fernandez, Hubert H. https://orcid.org/0000-0002-8553-5316
License Information

Text and Data Mining valid from 2025-03-22

Version of Record valid from 2025-03-22
More Information

Article History

Received: 3 February 2025

Accepted: 14 March 2025

First Online: 22 March 2025

Declarations

:

: The authors declare no conflicts of interest related to this study.